Upregulation and redistribution of integrin α6β4 expression occurs at an early stage in pancreatic adenocarcinoma progression

Modern Pathology

Volumn 20, Issue 6, 2007, Pages 656-667

  Cruz Monserrate, Zobeida ^a   Qiu, Suimin ^b   Evers, B Mark ^a,b   O'Connor, Kathleen L ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Chronic pancreatitis; Immunohistochemistry; Integrins; Pancreatic cancer; Pancreatic intraepithelial neoplasia (PanINs); Precursor lesion

Indexed keywords

ALPHA6BETA4 INTEGRIN; PROTEIN SUBUNIT;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CANCER GROWTH; CARCINOGENESIS; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PANCREAS; PANCREAS ADENOCARCINOMA; PANCREAS CELL; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SAMPLE; UPREGULATION;

ADENOCARCINOMA; CARCINOMA IN SITU; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA6BETA4; PANCREAS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 34249097492     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800782     Document Type: Article

References (45)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-130.
2. Li D, Xie K, Wolff R, et al. Pancreatic cancer. Lancet 2004;363:1049-1057.
3. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-586.
4. Hruban RH, Goggins M, Parsons J, et al. Progression model for pancreatic cancer. Clin Cancer Res 2000;6:2969-2972.
5. Kloppel G, Luttges J. The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians. Curr Gastroenterol Rep 2004;6:111-118.
6. Volkholz H, Stolte M, Becker V. Epithelial dysplasias in chronic pancreatitis. Virchows Arch A Pathol Anat Histol 1982;396:331-349.
7. Malka D, Hammel P, Maire F, et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 2002;51:849-852.
8. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993;328:1433-1437.
9. Taylor B. Carcinoma of the head of the pancreas versus chronic pancreatitis: diagnostic dilemma with significant consequences. World J Surg 2003;27:1249-1257.
10. Logsdon CD, Simeone DM, Binkley C, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003;63:2649-2657.
11. Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, et al. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol 2003;201:63-74.
12. Nakamura T, Furukawa Y, Nakagawa H, et al. Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 2004;23:2385-2400.
13. Gleason B, Adley B, Rao MS, et al. Immunohistochemical detection of the beta4 integrin subunit in pancreatic adenocarcinoma. J Histochem Cytochem 2005;53:799-801.
14. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-687.
15. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004;5:816-826.
16. Mercurio AM, Rabinovitz I. Towards a mechanistic understanding of tumor invasion - lessons from the alpha6beta 4 integrin. Semin Cancer Biol 2001;11:129-141.
17. Grossman HB, Lee C, Bromberg J, et al. Expression of the alpha6beta4 integrin provides prognostic information in bladder cancer. Oncol Rep 2000;7:13-16.
18. Hemler ME, Crouse C, Sonnenberg A. Association of the VLA alpha 6 subunit with a novel protein. A possible alternative to the common VLA beta 1 subunit on certain cell lines. J Biol Chem 1989;264:6529-6535.
19. Borradori L, Sonnenberg A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol 1999;112:411-418.
20. Rabinovitz I, Toker A, Mercurio AM. Protein kinase C-dependent mobilization of the alpha6beta4 integrin from hemidesmosomes and its association with actin-rich cell protrusions drive the chemotactic migration of carcinoma cells. J Cell Biol 1999;146:1147-1160.
21. Lipscomb EA, Mercurio AM. Mobilization and activation of a signaling competent alpha6beta4 integrin underlies its contribution to carcinoma progression. Cancer Metast Rev 2005;24:413-423.
22. Hiran TS, Mazurkiewicz JE, Kreienberg P, et al. Endothelial expression of the alpha6beta4 integrin is negatively regulated during angiogenesis. J Cell Sci 2003;116:3771-3781.
23. Feltri ML, Scherer SS, Nemni R, et al. Beta 4 integrin expression in myelinating Schwann cells is polarized, developmentally regulated and axonally dependent. Development 1994;120:1287-1301.
24. Mialhe A, Louis J, Pasquier D, et al. Expression of three cell adhesion molecules in bladder carcinomas: correlation with pathological features. Anal Cell Pathol 1997;13:125-136.
25. Falcioni R, Turchi V, Vittulo P, et al. Integrin beta4 expression in colorectal cancer. Int J Oncol 1994;5:573-578.
26. Tani T, Karttunen T, Kiviluoto T, et al. Alpha 6 beta 4 integrin and newly deposited laminin-1 and laminin-5 form the adhesion mechanism of gastric carcinoma. Continuous expression of laminins but not that of collagen VII is preserved in invasive parts of the carcinomas: implications for acquisition of the invading phenotype. Am J Pathol 1996;149:781-793.
27. Kitajiri S, Hosaka N, Hiraumi H, et al. Increased expression of integrin beta-4 in papillary thyroid carcinoma with gross lymph node metastasis. Pathol Int 2002;52:438-441.
28. Mariani Costantini R, Falcioni R, Battista P, et al. Integrin (alpha 6/beta 4) expression in human lung cancer as monitored by specific monoclonal antibodies. Cancer Res 1990;50:6107-6112.
29. Weinel RJ, Rosendahl A, Pinschmidt E, et al. The alpha 6-integrin receptor in pancreatic carcinoma. Gastroenterology 1995;108:523-532.
30. Lohr M, Trautmann B, Gottler M, et al. Expression and function of receptors for extracellular matrix proteins in human ductal adenocarcinomas of the pancreas. Pancreas 1996;12:248-259.
31. Dajee M, Lazarov M, Zhang JY, et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 2003;421:639-643.
32. Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997;57:2140-2143.
33. Hingorani SR, Petricoin EF, Maitra A, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003;4:437-450.
34. Ueda S, Takasuka N, Takeshita F, et al. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas. Carcinogenesis 2006;27:2497-2510.
35. Yu J, Ohuchida K, Mizumoto K, et al. Overexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer. World J Gastroenterol 2006;12:3878-3882.
36. Di Renzo MF, Poulsom R, Olivero M, et al. Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 1995;55:1129-1138.
37. Chung J, Yoon SO, Lipscomb EA, et al. The Met receptor and alpha 6 beta 4 integrin can function independently to promote carcinoma invasion. J Biol Chem 2004;279:32287-32293 [E-pub May 25, 2004].
38. Trusolino L, Bertotti A, Comoglio PM. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell 2001;107:643-654.
39. Bertotti A, Comoglio PM, Trusolino L. Beta4 integrin is a transforming molecule that unleashes Met tyrosine kinase tumorigenesis. Cancer Res 2005;65:10674-10679.
40. Jauliac S, Lopez-Rodriguez C, Shaw LM, et al. The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 2002;4:540-544.
41. Holzmann K, Kohlhammer H, Schwaenen C, et al. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Res 2004;64:4428-4433.
42. Chen M, O'Connor KL. Integrin alpha6beta4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells. Oncogene 2005;24:5125-5130.
43. Yiu GK, Toker A. NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J Biol Chem 2006;281:12210-12217.
44. Okami J, Yamamoto H, Fujiwara Y, et al. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin Cancer Res 1999;5:2018-2024.
45. Balthazar EJ. Pancreatitis associated with pancreatic carcinoma. Preoperative diagnosis: role of CT imaging in detection and evaluation. Pancreatology 2005;5:330-344.